"Designing Growth Strategies is in our DNA"
Epigenetics is an innovative field dealing with identifying and monitoring, the phenotypic changes in genes due to changes in the chromosomes, wherein the DNA sequence is not been affected. This field is generally implicated in the study of cancer, although other applications are expanding. Rising institutional and governmental collabration, and funding for development of new methods for disease diagnosis and treatment, are some of the factors anticipated to increase the demand for epignetics and hence driving the growth of the market. For instance, in February 2016, the University of Southampton and University Hospitals Southampton NHS Foundation Trust (UK) received USD 1.57 million (GBP 1 million) for genetics and genomics research related to cancer and infectious diseases.
Rising prevalnce of cancer globally along with growing applications epigenetics in non-oncology diseaes are some of the major factor driving the growth of the global epigentics market. According to WHO estimates, people suffering from cancer is expected to increase to 19.3 million by 2025 from 14.1 million in 2012. According to the American Cancer Society, in the U.S., the number of new cancer cases increased to 1,688,780 in 2017 from 1,685,210 in 2016.
Key Market Driver -
Rising prevalence of cancer
Key Market Restraint -
High cost of epigenetics instruments
However, the high cost of epigenetics instruments is one of the major factor hindering the market growth. For instance, Illumina’s NovaSeq 5000 and 6000 sequencers (launched in January 2017) are priced at USD 850,000 and USD 985,000, respectively.
By product type, the market is segmented into instruments, and consumables (enzymes, reagents, kits, etc.). Based on technology the market is segmented into DNA methylation, histone methylation, histone acetylation and others. Based on application, the market is segmented into oncology, infectious diseases, cardiovascular diseases and others. Based on end users, the epigenetics market is segmented into academic & research institutes, pharmaceutical and biotechnology companies, contract research organisations and others.
From a geographical standpoint, the market is categorized into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
The major companies in the global epigenetics market report includes Illumina, Inc., F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific, Inc., Eisai Co. Ltd., and Novartis AG. and others.
The global epigenetics market has been segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. North America followed by Europe dominated the global epigenetics market in 2018, owing to strong funding by government for research activities on epigenetics. Additionally, presence of advanced healthcare facilities and advancements in diagnostic procedures are some of the factor stimulating the growth of the regional market.
To gain extensive insights into the market, Request for Customization
For instance, in March 2015, Barts Cancer Institute’s Centre for Haemato-Oncology (UK) received funds worth USD 113.9 million (GBP 860,000) from the Medical Research Council to study epigenetics changes in cancer. Asia Pacific is estimated to witness a significant growth during forecast period due to rising disposable income, high unmet clinical needs of patients, increasing awareness about early diagnosis in emerging countries, such as India and China. Latin America and the Middle East and Africa are anticipated to hold significant share in epigenetics market during the forecast period of 2019-2026.
By Product Type
By End User
“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”- One of the Leading Food Companies in Germany
“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”- Intuitive Surgical
“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”- Major Food Company in Japan
“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”- Ziering Medical
“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”- Major Manufacturer of Precision Machine Parts in India
“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”- Hewlett-Packard
“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”- Global Management Consulting Firm
“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”- UK-based Start-up in the Medical Devices Sector
“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”- One of the Largest Companies in the Defence Industry